Immediate Impact
26 standout
Citing Papers
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Works of Xiaokun Hu being referenced
Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy
2024
ALT-803 in the treatment of non-muscle-invasive bladder cancer: Preclinical and clinical evidence and translational potential
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Xiaokun Hu | 57 | 28 | 65 | 93 | 68 | 52 | 366 | |
| Liye Liu | 47 | 41 | 81 | 153 | 36 | 35 | 363 | |
| Dejun Zhou | 33 | 14 | 140 | 132 | 114 | 39 | 370 | |
| Liang Shen | 15 | 25 | 65 | 85 | 85 | 29 | 393 | |
| Gökhan Demir | 34 | 11 | 83 | 52 | 99 | 31 | 397 | |
| Michael Pitiakoudis | 46 | 15 | 78 | 111 | 124 | 39 | 399 | |
| Yudan Wang | 31 | 10 | 16 | 55 | 110 | 29 | 379 | |
| Jingzhi Li | 40 | 24 | 100 | 39 | 70 | 31 | 377 | |
| Yongqiang Yang | 34 | 3 | 57 | 106 | 97 | 42 | 378 | |
| Hisashi Ishikura | 24 | 12 | 109 | 96 | 90 | 37 | 345 | |
| Yijuan Huang | 94 | 8 | 71 | 60 | 113 | 19 | 348 |
All Works
Login with ORCID to disown or claim papers
Loading papers...